Almost four years after CVS Health Corp. spent nearly $13 billion to acquire Omnicare, the long-term-care (LTC) pharmacy business attracted negative attention as a major contributor to “headwinds” in the company’s Feb. 20 report on fourth quarter and full-year 2018 financial results. “We certainly expected Omnicare performance to stabilize and improve,” CVS Health President and CEO Larry Merlo conceded during the earnings call that day.
- People on the Move
- Drug Benefits
- Datapoint, Medicare and Medicaid
- Abstract, Medicare and Medicaid
- Headlines in the News